This protocol, including an alternative gating strategy, showed a high correlation (R2 = 0.9975) with the original tube containing CD19, both in samples with CD19-positive and CD19-negative BCP-ALL cells. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.